Jingyu Xu

7PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersNanomedicineNeurology and neuromuscular diseasesMolecular targetsMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 07, 2026
Circulating tumor cells identify a disseminated genomic high-risk phenotype within IMS-IMWG 2025 staging in newly diagnosed multiple myeloma.

|Jan 10, 2026
Two Decades of Real-World Study in Newly Diagnosed Multiple Myeloma: Evolving Treatment and Outcomes in China with Reference to the United States.

Jingyu Xu, Meng Shu, Hsingwen Chung

|Aug 02, 2024
Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma.

Wenqiang Yan, Lihui Shi, Jingyu Xu

|Jun 20, 2024
Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing.

Jian Cui, Xiaoyun Li, Shuhui Deng

|Apr 12, 2024
Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma.

Jian Cui, Yuntong Liu, Rui Lv

|Jan 03, 2024
Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM).

Huishou Fan, Bing Wang, Lihui Shi

Pageof 2

Frequent Collaborators

7 joint publications

Lugui Qiu

6 joint publications

Gang An

6 joint publications

Jian Cui

6 joint publications

Chenxing Du